TARO - Taro Pharmaceutical EPS misses by $0.36 misses on revenue October, 28 2021 05:32 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $0.66 misses by $0.36. Revenue of $132M (-7.6% Y/Y) misses by $21.23M. Press Release For further details see: Taro Pharmaceutical EPS misses by $0.36, misses on revenue